Epitomics Inc

Website Links

Description

Epitomics, Inc. , an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology (RabMAb) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. It produces high quality antibodies and develops an enabling platform to use RabMAbs in the broad areas of research, diagnostics and therapeutics.Compared to currently available MAb technology on the market, such as mouse hybridoma, the Company's proprietary technology can generate RabMAbs more efficiently and can offer RabMAbs with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle.The Company aims to become the largest monoclonal antibody company that develops and commercializes RabMAb technology and products in research, diagnostics, and therapeutics. The Company is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China.

Products & services

Similar companies nearby